Share Email Print

Proceedings Paper

The optics inside an automated single molecule array analyzer
Author(s): William McGuigan; David R. Fournier; Gary W. Watson; Les Walling; Bill Gigante; David C. Duffy; David M. Rissin; Cheuk W. Kan; Raymond E. Meyer; Tomasz Piech; Matthew W. Fishburn
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

Quanterix and Stratec Biomedical have developed an instrument that enables the automated measurement of multiple proteins at concentration ~1000 times lower than existing immunoassays. The instrument is based on Quanterix’s proprietary Single Molecule Array technology (Simoa™ ) that facilitates the detection and quantification of biomarkers previously difficult to measure, thus opening up new applications in life science research and in-vitro diagnostics. Simoa is based on trapping individual beads in arrays of femtoliter-sized wells that, when imaged with sufficient resolution, allows for counting of single molecules associated with each bead. When used to capture and detect proteins, this approach is known as digital ELISA (Enzyme-linked immunosorbent assay). The platform developed is a merger of many science and engineering disciplines. This paper concentrates on the optical technologies that have enabled the development of a fully-automated single molecule analyzer. At the core of the system is a custom, wide field-of-view, fluorescence microscope that images arrays of microwells containing single molecules bound to magnetic beads. A consumable disc containing 24 microstructure arrays was developed previously in collaboration with Sony DADC. The system cadence requirements, array dimensions, and requirement to detect single molecules presented significant optical challenges. Specifically, the wide field-of-view needed to image the entire array resulted in the need for a custom objective lens. Additionally, cost considerations for the system required a custom solution that leveraged the image processing capabilities. This paper will discuss the design considerations and resultant optical architecture that has enabled the development of an automated digital ELISA platform.

Paper Details

Date Published: 27 February 2014
PDF: 13 pages
Proc. SPIE 8935, Advanced Biomedical and Clinical Diagnostic Systems XII, 89350X (27 February 2014); doi: 10.1117/12.2041706
Show Author Affiliations
William McGuigan, Stratec Biomedical USA (United States)
David R. Fournier, Quanterix Corp. (United States)
Gary W. Watson, Stratec Biomedical USA (United States)
Les Walling, Stratec Biomedical USA (United States)
Bill Gigante, Stratec Biomedical USA (United States)
David C. Duffy, Quanterix Corp. (United States)
David M. Rissin, Quanterix Corp. (United States)
Cheuk W. Kan, Quanterix Corp. (United States)
Raymond E. Meyer, Quanterix Corp. (United States)
Tomasz Piech, Quanterix Corp. (United States)
Matthew W. Fishburn, Quanterix Corp. (United States)

Published in SPIE Proceedings Vol. 8935:
Advanced Biomedical and Clinical Diagnostic Systems XII
Tuan Vo-Dinh; Anita Mahadevan-Jansen; Warren S. Grundfest M.D., Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?